Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 454

Similar articles for PubMed (Select 19117369)

1.

Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.

Marshall VL, Reininger CB, Marquardt M, Patterson J, Hadley DM, Oertel WH, Benamer HT, Kemp P, Burn D, Tolosa E, Kulisevsky J, Cunha L, Costa D, Booij J, Tatsch K, Chaudhuri KR, Ulm G, Pogarell O, Höffken H, Gerstner A, Grosset DG.

Mov Disord. 2009 Mar 15;24(4):500-8. doi: 10.1002/mds.22108.

PMID:
19117369
2.

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.

Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink MH, Sips HJ, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, Lees AJ, Costa DC, Gacinovic S, Oertel WH, Pogarell O, Hoeffken H, Joseph K, Tatsch K, Schwarz J, Ries V.

Mov Disord. 2000 May;15(3):503-10.

PMID:
10830416
3.

[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.

Lorberboym M, Treves TA, Melamed E, Lampl Y, Hellmann M, Djaldetti R.

Mov Disord. 2006 Apr;21(4):510-4.

PMID:
16250023
4.

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.

Benamer HT, Oertel WH, Patterson J, Hadley DM, Pogarell O, Höffken H, Gerstner A, Grosset DG.

Mov Disord. 2003 Sep;18(9):977-84.

PMID:
14502664
5.

Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.

Covelli EM, Brunetti A, Di Lauro A, Sullo P, Mazzarella G, Tedeschi E, Belfiore G.

Radiol Med. 2004 Oct;108(4):417-25. English, Italian.

PMID:
15525895
6.

Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.

Eshuis SA, Jager PL, Maguire RP, Jonkman S, Dierckx RA, Leenders KL.

Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):454-62. doi: 10.1007/s00259-008-0989-5. Epub 2008 Nov 27.

PMID:
19037637
7.

Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease.

Diaz-Corrales FJ, Sanz-Viedma S, Garcia-Solis D, Escobar-Delgado T, Mir P.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):556-64. doi: 10.1007/s00259-009-1289-4. Epub 2009 Oct 28.

PMID:
19862520
8.

123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.

Filippi L, Manni C, Pierantozzi M, Brusa L, Danieli R, Stanzione P, Schillaci O.

Nucl Med Commun. 2006 Apr;27(4):381-6.

PMID:
16531926
9.

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.

Sixel-Döring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C.

J Neurol. 2011 Dec;258(12):2147-54. doi: 10.1007/s00415-011-6076-z. Epub 2011 May 6.

PMID:
21547379
10.

Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.

Van Laere K, De Ceuninck L, Dom R, Van den Eynden J, Vanbilloen H, Cleynhens J, Dupont P, Bormans G, Verbruggen A, Mortelmans L.

Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1119-27. Epub 2004 Apr 3.

PMID:
15064872
11.

Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.

Marshall VL, Patterson J, Hadley DM, Grosset KA, Grosset DG.

Nucl Med Commun. 2006 Dec;27(12):933-7.

PMID:
17088677
12.
13.

123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.

Filippi L, Manni C, Pierantozzi M, Brusa L, Danieli R, Stanzione P, Schillaci O.

Nucl Med Commun. 2005 May;26(5):421-6.

PMID:
15838424
14.

Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.

Benítez-Rivero S, Marín-Oyaga VA, García-Solís D, Huertas-Fernández I, García-Gómez FJ, Jesús S, Cáceres MT, Carrillo F, Ortiz AM, Carballo M, Mir P.

J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):122-9. doi: 10.1136/jnnp-2012-302618. Epub 2012 Aug 20.

PMID:
22906618
15.

FP-CIT and MIBG scintigraphy in early Parkinson's disease.

Spiegel J, Möllers MO, Jost WH, Fuss G, Samnick S, Dillmann U, Becker G, Kirsch CM.

Mov Disord. 2005 May;20(5):552-61.

PMID:
15645531
16.

Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.

Verstappen CC, Bloem BR, Haaxma CA, Oyen WJ, Horstink MW.

Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):502-7. Epub 2006 Oct 20.

PMID:
17053905
17.

Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.

Doepp F, Plotkin M, Siegel L, Kivi A, Gruber D, Lobsien E, Kupsch A, Schreiber SJ.

Mov Disord. 2008 Feb 15;23(3):405-10.

PMID:
18067184
18.

[Differential diagnosis of parkinsonism using dopamine transporters brain SPECT].

Lorenzo Bosquet C, Miquel Rodríguez F, Roca Bielsa I, Milà M, Aguadé Bruix S, Castell Conesa J.

Med Clin (Barc). 2004 Mar 13;122(9):325-8. Spanish.

PMID:
15033050
19.

Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.

Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA.

J Nucl Med Technol. 2007 Mar;35(1):21-6.

20.

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.

Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K.

Arch Neurol. 2004 Aug;61(8):1224-9.

PMID:
15313838
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk